Eli Lilly | LLY - Debt

Stock Price
1,043.62
Daily Change
6.47 0.62%
Monthly
0.20%
Yearly
28.77%
Q1 Forecast
1,005.21

Eli Lilly reported $39.9B in Debt for its fiscal quarter ending in June of 2025.





Debt Change Date
AbbVie USD 1000K 70.48B Sep/2025
Abbott USD 12.94B 496M Sep/2025
ALKERMES USD 72.68M 293.32M Jun/2025
Amgen USD 56.2B 1.18B Jun/2025
AstraZeneca USD 32.84B 1.19B Jun/2025
Baxter International USD 9.73B 584M Jun/2025
Biogen USD 6.29B 309.5M Sep/2025
Bristol-Myers Squibb USD 50.93B 1.22B Jun/2025
Drreddys Laboratories INR 67.73B 19.09B Dec/2025
Eli Lilly USD 39.9B 1.39B Jun/2025
Gilead Sciences USD 24.95B 6M Jun/2025
GlaxoSmithKline GBP 17.35B 1.08B Jun/2025
Glaxosmithkline GBP 17.75B 396M Sep/2025
J&J USD 45.8B 4.97B Sep/2025
Medtronic USD 28.61B 93M Jun/2025
Merck USD 35.4B 558M Jun/2025
Neurocrine Biosciences USD 439.1M 8.4M Jun/2025
Novartis USD 32.64B 1.37B Jun/2025
Novartis USD 32.02B 615M Sep/2025
Novo Nordisk DKK 118.72B 61.75B Mar/2025
Perrigo USD 3.65B 454.7M Jun/2025
Pfizer USD 60.93B 3.42B Jun/2025
Prestige Brands USD 1.04B 27.25M Jun/2025
Regeneron Pharmaceuticals USD 2.71B 400K Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 21.76B 530M Sep/2025
Sanofi EUR 21.76B 530M Sep/2025
United Therapeutics USD 200M 100M Mar/2025
Zoetis USD 6.79B 1.11B Jun/2025